Guardant Health (NASDAQ: GH) Form 144 shows proposed insider sale of shares

Rhea-AI Filing Summary

Guardant Health filing: a Form 144 notice lists proposed dispositions of Common Stock tied to restricted stock lapses. The filing names Charles Schwab & Co., Inc. as broker and shows scheduled events on 01/15/2026 and 02/15/2026 for 250 and 98 shares respectively. The entries are labeled "Restricted Stock Lapse" and "Equity Compensation." No securities sold during the past three months are reported in the excerpt.

Insights

Securities Compliance Counsel

Routine Form 144 notice of proposed dispositions under Rule 144.

The filing lists proposed dispositions associated with restricted stock lapses: 250 shares dated 01/15/2026 and 98 shares dated 02/15/2026

These entries are procedural disclosures indicating intended sales; the excerpt does not show executed sales, proceeds, or whether sales occurred under a trading plan. Subsequent filings would record completed transactions if and when executed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	348	30655.00	131170441	03/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			250	01/15/2026	Equity Compensation
Common	02/15/2026	Restricted Stock Lapse	Guardant Health, Inc.			98	02/15/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Guardant Health's (GH) Form 144 report show?

It reports proposed dispositions tied to restricted stock lapses of 250 shares on 01/15/2026 and 98 shares on 02/15/2026. The broker is listed as Charles Schwab & Co., Inc. The filing does not show completed sales.

Does the Form 144 indicate actual sales for GH?

No; the excerpt lists proposed dispositions associated with "Restricted Stock Lapse" and shows no entries under "Securities Sold During The Past 3 Months." It therefore discloses intent to sell, not confirmed execution of sales.

Who is the broker or intermediary listed on the Form 144 for GH?

The filing names Charles Schwab & Co., Inc. at 3000 Schwab Way, Westlake, TX. That broker is identified in the excerpt as the intermediary associated with the proposed dispositions.

What dates are tied to the proposed dispositions on GH's Form 144?

The excerpt ties the proposed dispositions to 01/15/2026 (250 shares) and 02/15/2026 (98 shares). Each line is labeled with "Restricted Stock Lapse" and "Equity Compensation."